Covered recipient · General Payments record
NIRAJA SATHYANARAYANAN SURESH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$44,981.31
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,000.00 | 1 |
| Travel and Lodging | $1,904.46 | 5 |
| Food and Beverage | $597.21 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $7,102.69 | 13 |
| ABBVIE INC. | $227.69 | 4 |
| Alnylam Pharmaceuticals Inc. | $90.16 | 1 |
| Teva Pharmaceuticals USA, Inc. | $38.30 | 2 |
| Acerta Pharma LLC | $28.06 | 1 |
| Lilly USA, LLC | $14.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $115.06 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185113 | CMS |
| ABBVIE INC. | $20.71 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185115 | CMS |
| ABBVIE INC. | $87.73 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185117 | CMS |
| ABBVIE INC. | $4.19 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185119 | CMS |
| Alnylam Pharmaceuticals Inc. | $90.16 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125832153 | CMS |
| ARGENX US, INC. | $13.91 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142107501 | CMS |
| ARGENX US, INC. | $140.00 | 07/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142126513 | CMS |
| ARGENX US, INC. | $710.95 | 07/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142126569 | CMS |
| ARGENX US, INC. | $515.39 | 07/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142126541 | CMS |
| ARGENX US, INC. | $95.18 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142126571 | CMS |
| ARGENX US, INC. | $28.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142126551 | CMS |
| ARGENX US, INC. | $498.12 | 07/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142126561 | CMS |
| ARGENX US, INC. | $5,000.00 | 07/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142126539 | CMS |
| ARGENX US, INC. | $24.00 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142122226 | CMS |
| ARGENX US, INC. | $21.84 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142126543 | CMS |
| ARGENX US, INC. | $11.95 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142126549 | CMS |
| ARGENX US, INC. | $40.00 | 08/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142126559 | CMS |
| ARGENX US, INC. | $2.65 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127852 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.06 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104771332 | CMS |
| Lilly USA, LLC | $14.77 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135178573 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565162 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.20 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565202 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.